Designed and manufactured in Finland

Every year, more than 50 million surgical patients experience a post-operative adverse event (such as upper airway obstruction, internal bleeding, sepsis, and respiratory or cardiac arrest) that can rapidly become fatal. 4.2 million of these patients die within 30 days after surgery (equal to 7.7% of all deaths worldwide).


Almost all these events and deaths are preceded by warning signs for an average of 6-8 hours, so if acted upon fast enough, better health outcomes could be achieved with lower costs and estimably 50% of these deaths could be prevented.


However, due to problems with current solutions, the intensity of patient monitoring decreases as the patient moves from the intensive care via general ward towards home. Thus the signs of deterioration are often overlooked or not detected at all.


The trend with current solutions is single-use sensors, which causes high costs. Another problem is the alarm fatigue caused by simple threshold-based alarms. The third major issue is poor patient adherence due to itching adhesives of the stick-on single-use sensors that a patient needs to wear for 5-10 days.


So there is a clear need for less expensive, smarter, and better conformance monitoring systems to ensure continuous vital signs monitoring, both in hospital wards and after discharge home.To identify deterioration and trigger appropriate management earlier, and thus save both costs and lives




We have developed a multi-sensor wearable technology that continuously monitors patients’ vital signs and ensures early warning of deterioration in both hospital and home settings.

The disruptiveness of our solution is based on the combination of:

The exceptionally compact and comfortable form factor that integrates the best available sensor, power and wireless technologies to ensure highest patient adherence with the least cost.

AI and machine learning based self-learning capabilities are providing increasingly accurate alarms to avoid any alarm fatigue.

A scalable, profitable business model that supports reusable sensor solution and adapts to hospitals’ daily routines, making the implementation financially feasible


For hospitals:

The net benefits for a hospital with 30 000 patients are expected to reach €5 million annually, with the main impact components being:


• Safe reduction of Length of Stay (LOS) in the hospital.


• Reduced number of avoidable re-admissions to the Intensive Care Unit (ICU).


• Faster re-admission to ICU for patients who do need escalation of care.

For patients:

Better health outcomes by preventing death and disability. We project that our solution will be used to monitor and benefit a total of 7.7millionpatients by the end of 2025

Emfi, Emfit, EMFIT QS, QS Quantified, QS+CLINICAL, QS+CARE, QS+ACTIVE, QS+RESEARCH, QS SERVICE, Sensing What Matters, QS Quantified logo, and Emfit logo are registered trademarks or trademarks of Emfit Ltd in EU, USA, China and other countries.  © Emfit Ltd 2004-2019. All rights reserved. Patents granted and pending for. All specifications are subject to change without prior notice.